SAN FRANCISCO (MedPage Today) -- Some hepatitis C patients who don't respond to standard therapy may get a second chance at eradication with daily interferon alfacon-1 (Infergen) plus ribavirin.
Interferon and Ribavirin Second-Line Option for Hepatitis C (CME...Courtesy MedPage Today Infectious Disease Tue, 06/02/2009 - 14:16
SAN FRANCISCO (MedPage Today) -- Some hepatitis C patients who don't respond to standard therapy may get a second chance at eradication with daily interferon alfacon-1 (Infergen) plus ribavirin. More related itemsDifficult HCV Type Responds to Novel Protease...
AASLD: Less Immunosuppression Lowers Mortality After...
New Combo KOs HCV Without Interferon, Ribavirin...
Burt's Bees - Baby Bee Buttermilk Lotion, 7 fl oz...
ghd MK4 Professional Advanced Ceramic Heat-Styler, 1"
|
Popular by tags WeekMonth |
Post new comment